Carlos Kengla

Dr. Carlos Kengla

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2016 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
HKHyun-Wook Kang
Hyun-Wook Kang
SLSang Jin Lee
Sang Jin Lee
IKIn Kap Ko
In Kap Ko
CKCarlos Kengla
Carlos Kengla
JYJames J Yoo
James J Yoo
AAAnthony Atala
Anthony Atala

31 December 2019 in Biofabrication
Verified
Journal Article
Closed access
PDF file
DKDongxu Ke
Dongxu Ke
HYHualin Yi
Hualin Yi
SESavannah Est-Witte
Savannah Est-Witte
SGSunil K George
Sunil K George
CKCarlos Kengla
Carlos Kengla
Sean MurphySean Murphy
Sean Murphy
Tracheal stenosis is a rare but life-threatening disease. Primary clinical procedures for treating this disease are limited if the region requiring repair is long or complex. This study is the first of its kind to fabricate bioprinted tracheal constructs with separate cartilage and smooth muscle regions using polycaprolactone (PCL) and human mesenchymal stem cell (hMSC)-laden hydrogels. Our final bioprinted trachea showed comparable elastic modulus and yield stress compared to native tracheal tissue. In addition, both cartilage and smooth muscle formation were observed in the desired regions of our bioprinted trachea through immunohistochemistry and western blot after two weeks of in vitro culture. This study demonstrates a novel approach to manufacture tissue engineered trachea with mechanical and biological properties similar to native trachea, which represents a step closer to overcoming the clinical challenges of treating tracheal stenosis.

1 June 2019 in Applied Physics Reviews
Verified
Journal Article
Closed access
PDF file
ASAshkan Shafiee
Ashkan Shafiee
EGElham Ghadiri
Elham Ghadiri
HRHaripriya Ramesh
Haripriya Ramesh
CKCarlos Kengla
Carlos Kengla
JKJareer Kassis
Jareer Kassis
AAAnthony Atala
Anthony Atala
Bioprinters are being extensively used for different applications in life sciences and medicine in general and more specifically in regenerative medicine, tissue, and organ fabrication. The technology has matured from its purely academic origin owing to the involvement of materials science, engineering, biology, and physics, as well as commercial entities. Nevertheless, despite the progress in the science and the understanding of the mechanisms underlying the various bioprinting technologies, further efforts are needed to develop more quantitative strategies. In particular, predictive modeling is necessary to optimize the printing parameters and thus enhance the quality of the final products. Here, we review the physics that underpins the most commonly employed approaches, such as extrusion, laser-based, and inkjet bioprinting. We provide an overview of the relevant parameters, their inter-relationships, and the equations that govern the various printing processes and thus allow for their optimization. We present our perspective on the field and views on future strategies for its further advancement. Our intention with this review is to provide the practitioners of bioprinting with additional tools to enhance the quantitative aspects of their work and move the technology beyond its early, mostly “trial and error” character.

1 December 2017 in 3D Printing and Additive Manufacturing
Verified
Journal Article
Closed access
CKCarlos Kengla
Carlos Kengla
EREric Renteria
Eric Renteria
CWColleen Wivell
Colleen Wivell
AAAnthony Atala
Anthony Atala
JYJames J. Yoo
James J. Yoo
SLSang Jin Lee
Sang Jin Lee
As technologies have advanced around medical imaging and additive manufacturing, intersections are producing enabling technologies that augment the medical sciences. Three-dimensional (3D) bioprinting, in particular, is emerging as a promising enabling technology for tissue engineering and regenerative medicine applications. In this study, we developed a workflow to take 3D medical images and utilized them for bone construct design, bioprinting, and in vivo validation. Medical imaging and 3D bioprinting strategy converged to allow the fabrication of a structure with complex shape and inner architecture based on patient anatomy and biomimicry. The workflow demonstrated the power of the technological intersection and the need for further software development to harness and, eventually, explore potential clinical applications. The outcome of this study validated the concept that patient-specific anatomy could be translated to 3D bioprinting strategy through medical imaging and image processing software with strong clinical relevance.

18 September 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
WNWEI NIE
WEI NIE
XDXinyi Dai
Xinyi Dai
JCJoshua Scott Copus
Joshua Scott Copus
CKCarlos Kengla
Carlos Kengla
RXRongyuan Xie
Rongyuan Xie
Chuanglong HeChuanglong He
Chuanglong He

1 January 2017
Verified
Book Chapter
Closed access
CKCarlos Kengla
Carlos Kengla
AKAmritha Kidiyoor
Amritha Kidiyoor
SMSean V. Murphy
Sean V. Murphy